Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 13/20 | 0.57 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.57 |
| ▸ | SLC7A5 | Q01650 | 6/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3475085 | 1.00 | KIF11 (0.57) | KIF11KCNH2SLC7A5ALDH1A1 | |
| SCHEMBL529077 | 0.87 | KIF11 (0.46) | KIF11SLC7A5 | |
| SCHEMBL27914480 | 0.87 | KIF11 (0.46) | KIF11SLC7A5 | |
| SCHEMBL5023008 | 0.85 | KIF11 (0.56) | KIF11KCNH2SLC7A5ALDH1A1 | |
| SCHEMBL21931379 | 0.82 | KIF11 (0.54) | KIF11KCNH2ALDH1A1 | |
| Acetic Acid SCHEMBL30066547 | 0.81 | CPB2 (0.41) | KIF11 | |
| SCHEMBL31217761 | 0.80 | KIF11 (0.67) | KIF11KCNH2 | |
| SCHEMBL2390381 | 0.80 | HRH1 (0.50) | KIF11KCNH2 | |
| SCHEMBL29060869 | 0.77 | KIF11 (0.88) | KIF11KCNH2 | |
| SCHEMBL29864858 | 0.76 | KIF11 (0.55) | KIF11KCNH2SLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10240189-B2 | Solid support assay systems and methods utilizing non-standard bases | LUMINEX CORPORATION (US) | 2019-03-26 | — | — | US | disclosed |
| US-9611509-B2 | Materials and methods for detection of nucleic acids | LUMINEX CORPORATION (US) | 2017-04-04 | — | — | US | disclosed |
| US-20150132759-A1 | SOLID SUPPORT ASSAY SYSTEMS AND METHODS UTILIZING NON-STANDARD BASES | LUMINEX CORP (US) | 2015-05-14 | — | — | US | disclosed |
| US-8969047-B2 | Solid support assay systems and methods utilizing non-standard bases | LUMINEX CORPORATION (US) | 2015-03-03 | — | — | US | disclosed |
| US-20140057269-A1 | Materials and Methods for Detection of Nucleic Acids | LUMINEX CORPORATION (US) | 2014-02-27 | — | — | US | disclosed |
| US-20140024550-A1 | Solid Support Assay Systems and Methods Utilizing Non-Standard Bases | LUMINEX CORPORATION (US) | 2014-01-23 | — | — | US | disclosed |
| US-8518671-B2 | Solid support assay systems and methods utilizing non-standard bases | LUMINEX CORPORATION (US) | 2013-08-27 | — | — | US | disclosed |
| US-8519117-B2 | Materials and methods for detection of nucleic acids | LUMINEX CORPORATION (US) | 2013-08-27 | — | — | US | disclosed |
| US-20120295808-A1 | Solid Support Assay Systems and Methods Utilizing Non-Standard Bases | GRENIER JENNIFER K (US) | 2012-11-22 | — | — | US | disclosed |
| US-8217160-B2 | Determining which allele is present in a sample tot reduce non-specific hybridization or reduce the impact of non-specific hybridization on the assay by using oligonucleotides having at least on non-standard base (iscytosine and isoguanine); kits | ERAGEN BIOSCIENCES, INC. (US) | 2012-07-10 | — | — | US | disclosed |
| US-7422850-B2 | Materials and methods for detection of nucleic acids | ERAGEN BIOSCIENCES, INC. (US) | 2008-09-09 | — | — | US | disclosed |
| US-20070087361-A1 | Solid support assay systems and methods utilizing non-standard bases | ERAGEN BIOSCIENCES, INC. | 2007-04-19 | — | — | US | disclosed |
| US-20070031885-A1 | Materials and methods for detection of nucleic acids | ERAGEN BIOSCIENCES, INC. | 2007-02-08 | — | — | US | disclosed |
| US-20060252091-A1 | Materials and methods for detection of nucleic acids | ERAGEN BIOSCIENCES, INC. | 2006-11-09 | — | — | US | disclosed |
| US-20060078936-A1 | Solid support assay systems and methods utilizing non-standard bases | ERAGEN BIOSCIENCES, INC. | 2006-04-13 | — | — | US | disclosed |
| US-6977161-B2 | Solid support assay systems and methods utilizing non-standard bases | ERAGEN BIOSCIENCES, INC. (US) | 2005-12-20 | — | — | US | disclosed |
| US-20040106108-A1 | Solid support assay systems and methods utilizing non-standard bases | ERAGEN BIOSCIENCES, INC. (US) | 2004-06-03 | — | — | US | disclosed |
| EP-1358352-A2 | SOLID SUPPORT ASSAY SYSTEMS AND METHODS UTILIZING NON-STANDARD BASES | Eragen Biosciences, Inc. (US) | 2003-11-05 | — | — | EP | disclosed |
| US-20020150900-A1 | Materials and methods for detection of nucleic acids | LUMINEX CORPORATION | 2002-10-17 | — | — | US | disclosed |
| WO-2002033126-A2 | SOLID SUPPORT ASSAY SYSTEMS AND METHODS UTILIZING NON-STANDARD BASES | ERAGEN BIOSCIENCES, INC. (US) | 2002-04-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070031885-A1 | Materials and methods for detection of nucleic acids | POLRMT, RNGTT, ADAR | KIF11 4200/4885KCNH2 4509/4885SLC7A5 4258/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.